发明名称 DERIVATIVES OF 2-(1,2,4-TRIAZOLE-1-YL)-1,3,4-THIADIAZOLE, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION AND INTERMEDIATE COMPOUND
摘要 organic chemistry, pharmacy. SUBSTANCE: invention relates to novel derivatives of 2- (1,2,4-triazole-1-yl)-1,3,4-thiadiazole of the formula (I) where R1 means hydrogen atom, C1-4-alkyl group or phenyl group that can be substituted with from 1 to 3 substituents taken among the group including halogen atom, hydroxy-group, nitro-group, C1-4-alkoxy-group, (C1-4- alkyl)-amino-group and di-(-alkyl)-amino-group; or the group of the formula (a) C1-4; Z means hydrogen atom or C1-4-alkoxy-group; R0 means the group of the formula Alk-NR4R5 where Alk is alkylene group with direct or branched C1-6-chain; one of R2 and R3 means amino-group and another one means amino-group or 5-6-membered saturated heterocyclic group including one or two nitrogen and/or oxygen atoms that is bound through its nitrogen atom being the indicated heterocyclic group can be substituted with C1-4-alkyl group, phenyl group or halogenphenyl group or the latter of R2 and R3 means the group of the formula -SR. Compounds show effect on heart and central nervous system. Also, invention describes method of synthesis of novel compounds, intermediate substances and pharmaceutical compositions based on these novel compounds. EFFECT: new compounds indicated above, improved method of synthesis, valuable medicinal properties. 18 cl, 4 tbl
申请公布号 RU2180903(C2) 申请公布日期 2002.03.27
申请号 RU19990118591 申请日期 1998.01.13
申请人 EHGISH D'ED'SERD'JAR RT. 发明人 REITER JOZHEF;BARKOTSI JOZHEF;BERETS GABOR;SHIMIG D'JULA;EHD'ED ANDRASH;IVANICHNE MED'ERI KATALIN;DRABANI SHANDOR;KERTES SABOLCH;MIKLOSHNE KOVACH ANIKO;NAD'NE D'ENESH IL'DIKO;SECHEJNE KHEGEDISH MARIJA;SENASHI GABOR;VELLMANN JANOSH;PALLAGI KATALIN;SHMIDT EVA;TIKHAN'I KAROJ;TRINKA PETER;CHERGE MARGIT
分类号 A61K31/433;A61K31/454;A61K31/496;A61K31/535;A61K31/5377;A61P9/06;A61P9/08;A61P9/10;A61P25/06;A61P25/18;A61P25/22;C07D285/135;C07D417/04;C07D417/14;(IPC1-7):C07D417/04 主分类号 A61K31/433
代理机构 代理人
主权项
地址